GlassScriptPhysician profile
Patrick R Pritchard
NPI 1619901253
$4,778.48
in general payments reported to CMS, 2019-2025
11 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,126 · 2020: $14.47 · 2021: $549 · 2022: $676 · 2023: $236 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $181 · Education: $137 · Food and Beverage: $94.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $181.47 |
| Education | $137.01 |
| Food and Beverage | $94.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $2,600.06 | 2019 | |
| Stryker Corporation | $518.06 | 2022 | |
| Medtronic, INC. | $434.48 | 2021-2023 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $274.08 | 2019 | |
| Globus Medical, INC. | $261.63 | 2021 | |
| Nuvasive, INC. | $246.54 | 2022-2023 | Xlif |
| Medtronic USA, INC. | $158.51 | 2019-2020 | |
| Medical Device Business Services, INC. | $137.01 | 2025 | Stratafix |
| Nevro Corp. | $107.61 | 2019 | |
| Bioventus LLC | $40.50 | 2025 | Bonescalpel & Sonicone (O.R.) |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Pritchard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.